RESUMO
Objectives: A study was made of the effect of nonsurgical periodontal treatment upon blood glucose control intype 2 diabetics with periodontal disease.Study design: A pre-post repeated measures analytical design was used, with a PubMed search of the related articlespublished up until December 2008.Results: The improvement in glycosylated hemoglobin (HbA1c) after nonsurgical periodontal treatment on comparing the baseline (8.0290±1.5539) and final values (7.7806±1.5636) was 0.2483±0.1171, and proved statistically significant (p=0.042). Conclusions: A decrease in HbA1c was observed after treatment, thus indicating improved blood glucose controlin type 2 diabetics with periodontal disease (AU)
No disponible
Assuntos
Humanos , Doenças Periodontais/complicações , Diabetes Mellitus Tipo 2/complicações , Doenças Periodontais/terapia , Índice Glicêmico , Hemoglobinas Glicadas/análiseRESUMO
Bisphosphonates inhibit bone resorption and are used to treat a range of pathologies, including Paget disease, osteoporosis,multiple myeloma and metastases associated with breast or prostate cancer. At present, there is no effectivetreatment for bisphosphonate induced osteonecrosis, so prevention is extremely important. Since quality oflife deteriorates for those suffering osteonecrosis, maximum precautions should be taken with patients at risk, andespecially whenever oral surgery, including dental implant placement, is contemplated. Dentists and oral or maxillofacialsurgeons must keep up to date with the latest approaches to prevention, particularly when treating patientswho are presently taking, or who will be taking bisphosphonates and are also candidates for dental implants (AU)
No disponible